BRIEF-Starpharma Holdings Says Viraleze To Be Launched In The UK
- ByReuters-
March 25 (Reuters) - Starpharma Holdings Ltd SPL.AX :* VIRALEZE TO BE LAUNCHED WITH LLOYDSPHARMACY IN THE UK
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
0.685
+0.015(+2.24%)
- Volume:318,589
- Bid/Ask:0.680/0.685
- Day's Range:0.650 - 0.720
SPL Overview
- Prev. Close
- 0.67
- Day's Range
- 0.65-0.72
- Revenue
- 4.23M
- Open
- 0.65
- 52 wk Range
- 0.62-1.545
- EPS
- -0.04
- Volume
- 318,589
- Market Cap
- 281.14M
- Dividend (Yield)
- N/A(N/A)
- Average Volume (3m)
- 372,543
- P/E Ratio
- -
- Beta
- 1.23
- 1-Year Change
- -52.7%
- Shares Outstanding
- 407,444,414
- Next Earnings Date
- 30 Aug 2022
What is your sentiment on Starpharma Holdings?
or
Vote to see community's results!
Starpharma Holdings Ltd News
- BRIEF-Starpharma Holdings Reports HY Loss Of $10.4 Mln
- ByReuters-
Feb 25 (Reuters) - Starpharma Holdings Ltd SPL.AX :* REPORTED LOSS FOR HALF-YEAR OF $10.4M
- BRIEF-Starpharma Holdings Says Viraleze Antiviral Nasal Spray Registered In Europe
- ByReuters-
Feb 23 (Reuters) - Starpharma Holdings Ltd SPL.AX :* STARPHARMA HOLDINGS LTD - VIRALEZE ANTIVIRAL NASAL SPRAY REGISTERED IN EUROPE
Starpharma Holdings Ltd Company Profile
Starpharma Holdings Ltd Company Profile
Starpharma Holdings Limited is an Australia-based global biopharmaceutical company engaged in the development of pharmaceutical and medical products based on polymers called dendrimers. Its programs for respiratory viruses, Dendrimer Enhanced Product (DEP) drug delivery and VivaGel. The Company’s products include VIRALEZE, VivaGel condom and VivaGel BV. VIRALEZE product is applied to the nasal cavity where respiratory viruses that cause colds, flu, and more severe respiratory illness, attach and start to multiply. VIRALEZE also provides a moisturizing and protective barrier in the nose and contains SPL7013. VivaGel is an agent applied to a range of marketed women’s health and sexual wellness products. VivaGel BV is a novel therapy for bacterial vaginosis (BV), the vaginal infection. VivaGelBV is available for sale under the brand names Betafem BV Gel (UK), Betadine BV (Europe), Betadine BV Gel (Asia) and Fleurstat BVgel (Australia & New Zealand) and licensed in over 160 countries.
Read More
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Strong Buy | Sell | Strong Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Sell | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Sell | Strong Sell |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 4.84 | 4.93 | 4.77 | -0.11 | -2.22% | 77.11K | Sydney | |||
| 32.03 | 32.50 | 32.02 | -0.790 | -2.41% | 2.04M | Sydney | |||
| 3.895 | 3.91 | 3.88 | +0.005 | +0.13% | 2.74M | Sydney | |||
| 7.485 | 7.57 | 7.46 | -0.055 | -0.73% | 3.19M | Sydney | |||
| 0.77 | 0.79 | 0.76 | 0.00 | 0.00% | 296.95K | Sydney | |||
| 3.69 | 3.73 | 3.68 | +0.020 | +0.54% | 1.54M | Sydney | |||
| 91.74 | 92.41 | 91.73 | -1.260 | -1.35% | 438.11K | Sydney | |||
| 0.225 | 0.235 | 0.225 | -0.010 | -4.26% | 1.34M | Sydney | |||
| 105.19 | 105.67 | 104.945 | -1.040 | -0.98% | 215.46K | Sydney | |||
| 1.765 | 1.77 | 1.76 | +0.005 | +0.28% | 216.65K | Sydney | |||
| 1.28 | 1.335 | 1.275 | -0.040 | -3.03% | 602.84K | Sydney | |||
| 13.37 | 13.54 | 13.30 | -0.24 | -1.76% | 297.42K | Sydney | |||
| 18.49 | 18.72 | 18.47 | +0.290 | +1.59% | 1.07M | Sydney | |||
| 2.79 | 2.93 | 2.79 | -0.10 | -3.46% | 508.85K | Sydney | |||
| 6.895 | 6.96 | 6.85 | -0.085 | -1.22% | 168.78K | Sydney |